Skip to main content
[Preprint]. 2024 Jul 23:rs.3.rs-4746484. [Version 1] doi: 10.21203/rs.3.rs-4746484/v1

Figure 1. Overview of clinical cytology samples profiled by MSK-IMPACT.

Figure 1

a The composition of the cytology cohort by sample preparation type, either cellblock (CB) or supernatant cfDNA (ScfDNA), and their respective collection method of either fine needle aspiration (FNA) or cytology fluid (e.g. pleural fluids, bronchial washes, ascites fluid, etc.). b The distribution of cancer types profiled by MSK-IMPACT clinically from cytology samples. The most common cancer types are at the top and are ordered in descending order for specific cancer types. Represented are all cytology samples and by sample type. c The distribution of testing outcome and sample type of cytology samples. In cytology cases that failed testing for MSK-IMPACT the cause of failure is further broken down with the corresponding number of sample type for each reason.